Home › Researcher directory › Jay T. Backstrom

Jay T. Backstrom

Affiliation : Acceleron Pharma (United States)

2Publications (affiliation in the United States)
50Total publications
5561Citations
17h-index

Research profile

Jay T. Backstrom has 2 indexed publications (2020). Their work appears in “Blood”. Their most cited article, “Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia i” (2020), has been cited 11 times. Their work is co-authored with at least 5 researchers.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

Acute Myeloid Leukemia Research
Retinoids in leukemia and cellular processes
Hematopoietic Stem Cell Transplantation
Hemoglobinopathies and Related Disorders
Pharmacovigilance and Adverse Drug Reactions

Publications (2)

Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia in the Believe Trial
2020 · Blood · cited 11 times
Sustained Reductions in Red Blood Cell (RBC) Transfusion Burden and Events in β-Thalassemia with Luspatercept: Longitudinal Results of the Believe Trial
2020 · Blood · cited 8 times

Collaborations

Partner institutions : Bristol-Myers Squibb (United States) · University of Southern California · Children's Hospital Los Angeles · University of California, San Francisco · UCSF Benioff Children's Hospital

Co-authors

Bibliographic data from OpenAlex (open database).